Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Schramm

Showing results (161-170 of 228) with videos related to

Pageof 23
Sort By:
Molecular Cancer Therapeutics|August 13, 2009
Xenogeneic immunization with human tyrosine hydroxylase DNA vaccines suppresses growth of established neuroblastomaNicole Huebener, Stefan Fest, Kerstin Hilt, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|June 13, 2024
Successful Desensitization with Imlifidase and Daratumumab in a Highly Immunized, Crossmatch Positive, Blood Group-Incompatible Living-Donor Re-Transplant Recipient with Systemic Lupus Erythematosus and Antiphospholipid SyndromeEva Schrezenmeier, Mira Choi, Brigitta Globke, et al.
Oncogene|January 8, 2005
Microarray analysis reveals differential gene expression patterns and regulation of single target genes contributing to the opposing phenotype of TrkA- and TrkB-expressing neuroblastomasJohannes H Schulte, Alexander Schramm, Ludger Klein-Hitpass, et al.
Thoracic Cancer|June 16, 2022
The clinical utility of cfRNA for disease detection and surveillance: A proof of concept study in non-small cell lung cancerMartin Metzenmacher, Balazs Hegedüs, Jan Forster, et al.
International Journal of Cancer|July 29, 2011
Dickkopf-3 is regulated by the MYCN-induced miR-17-92 cluster in neuroblastomaSara De Brouwer, Pieter Mestdagh, Irina Lambertz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2010
Chromosomal and microRNA expression patterns reveal biologically distinct subgroups of 11q- neuroblastomaPatrick G Buckley, Leah Alcock, Kenneth Bryan, et al.
Archives of Otolaryngology--Head & Neck Surgery|December 17, 2008
Speech and swallowing impairment after treatment for oral and oropharyngeal cancerMaria-Mercedes Suarez-Cunqueiro, Alexander Schramm, Ralf Schoen, et al.
Journal of Extracellular Biology|June 8, 2026
Single-EV Analyses Require Rigorous Antibody Qualification: PD-L1 Profiling in Cell Models and Patient PlasmaTobias Tertel, Fabiola Nardi Bauer, Oumaima Stambouli, et al.
International Journal of Cancer|November 11, 2006
High resolution tiling-path BAC array deletion mapping suggests commonly involved 3p21-p22 tumor suppressor genes in neuroblastoma and more frequent tumorsJasmien Hoebeeck, Evi Michels, Björn Menten, et al.
Nature Cell Biology|August 7, 2012
Synthetic lethality between Rb, p53 and Dicer or miR-17-92 in retinal progenitors suppresses retinoblastoma formationDavid Nittner, Irina Lambertz, Frederic Clermont, et al.
Pageof 23

Showing results (161-170 of 228) with videos related to

Sort By:
Pageof 23
Molecular Cancer Therapeutics|August 13, 2009
Xenogeneic immunization with human tyrosine hydroxylase DNA vaccines suppresses growth of established neuroblastomaNicole Huebener, Stefan Fest, Kerstin Hilt, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|June 13, 2024
Successful Desensitization with Imlifidase and Daratumumab in a Highly Immunized, Crossmatch Positive, Blood Group-Incompatible Living-Donor Re-Transplant Recipient with Systemic Lupus Erythematosus and Antiphospholipid SyndromeEva Schrezenmeier, Mira Choi, Brigitta Globke, et al.
Oncogene|January 8, 2005
Microarray analysis reveals differential gene expression patterns and regulation of single target genes contributing to the opposing phenotype of TrkA- and TrkB-expressing neuroblastomasJohannes H Schulte, Alexander Schramm, Ludger Klein-Hitpass, et al.
Thoracic Cancer|June 16, 2022
The clinical utility of cfRNA for disease detection and surveillance: A proof of concept study in non-small cell lung cancerMartin Metzenmacher, Balazs Hegedüs, Jan Forster, et al.
International Journal of Cancer|July 29, 2011
Dickkopf-3 is regulated by the MYCN-induced miR-17-92 cluster in neuroblastomaSara De Brouwer, Pieter Mestdagh, Irina Lambertz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2010
Chromosomal and microRNA expression patterns reveal biologically distinct subgroups of 11q- neuroblastomaPatrick G Buckley, Leah Alcock, Kenneth Bryan, et al.
Archives of Otolaryngology--Head & Neck Surgery|December 17, 2008
Speech and swallowing impairment after treatment for oral and oropharyngeal cancerMaria-Mercedes Suarez-Cunqueiro, Alexander Schramm, Ralf Schoen, et al.
Journal of Extracellular Biology|June 8, 2026
Single-EV Analyses Require Rigorous Antibody Qualification: PD-L1 Profiling in Cell Models and Patient PlasmaTobias Tertel, Fabiola Nardi Bauer, Oumaima Stambouli, et al.
International Journal of Cancer|November 11, 2006
High resolution tiling-path BAC array deletion mapping suggests commonly involved 3p21-p22 tumor suppressor genes in neuroblastoma and more frequent tumorsJasmien Hoebeeck, Evi Michels, Björn Menten, et al.
Nature Cell Biology|August 7, 2012
Synthetic lethality between Rb, p53 and Dicer or miR-17-92 in retinal progenitors suppresses retinoblastoma formationDavid Nittner, Irina Lambertz, Frederic Clermont, et al.
Pageof 23